about
Protein profile of exosomes from trabecular meshwork cellsIs there a new dawn for selective mineralocorticoid receptor antagonism?Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.Dietary sodium restriction decreases insulin secretion without affecting insulin sensitivity in humansAldosterone postnatally, but not at birth, is required for optimal induction of renal mineralocorticoid receptor expression and sodium reabsorption.Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.Patient knowledge of blood pressure target is associated with improved blood pressure control in chronic kidney diseaseAldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in miceBradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibitionInflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humansEndogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysisAldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high saltHuman interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.The renin-angiotensin-aldosterone system and glucose homeostasis.Utility of bone marrow biopsy for rapid diagnosis of febrile illnesses in patients with human immunodeficiency virus infection.The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance.Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanismBlood pressure targets in hemodialysis patientsSodium intake, ACE inhibition, and progression to ESRDSound Science before Quick Judgement Regarding RAS Blockade in COVID-19Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study
P50
Q24294431-E9FC5C6B-1B14-4C30-A724-2A12D71E2565Q27027792-9CDDABB8-8F97-452A-ACF2-86932241859CQ27343126-324691A3-28E2-4B92-B141-22E48FB0538BQ34284717-A961EBA4-6E2C-4405-9F3D-7E383B6D44DFQ35001362-12D8AB02-F323-4AC7-930D-CF431085FB8AQ35551235-32FE0171-066D-4BFD-AFC3-30B8B2BB0345Q35715691-64463DC4-EB69-4777-A33A-C5CBADBE1E49Q36113357-234D340F-2757-4488-919F-B93C86F5312CQ36210088-912F4EA1-7BAC-4A57-893B-3AC28C7656C6Q36672857-73779353-9390-473A-8851-24720194382DQ36968558-335B4696-7883-401F-A7FE-7AC6C65F1909Q37252413-737E4B9B-2DA2-4E66-ACD1-DEAA92009228Q37367707-6D7957CD-596C-497C-BFB2-9F92D4EE2F1DQ37406166-6DE79B7C-1319-456B-82E6-AB55706E38F1Q37502129-194CE0D5-CD9B-4570-82F0-DBF0928102DBQ37924374-1B4A4EEB-98EC-4006-B56F-E9D27133934CQ40617345-07F3D4BD-9A07-433F-BC5C-C5633771F3D2Q46407151-7674BA83-0645-4232-A9E5-18D13A9082DBQ46706342-4D856981-8FD3-442D-99D1-6E3A761C72B4Q53618165-9723796F-918D-4BEB-9C0D-D6F4D2972554Q79249916-D82AAFBA-C776-40F8-940B-BED0862FE4CCQ80795080-9C0BEAA2-E547-4C9E-94CB-4D6D72AC5147Q82983253-707DD30E-1F49-4960-8B2C-EACF19C80650Q90711199-66BEED60-A760-442F-BA0C-4D7376613A82Q91486037-9A0B17CB-0AF6-42DC-8649-DCFC2BFDA878
P50
description
hulumtues
@sq
onderzoeker
@nl
physician
@en
հետազոտող
@hy
name
James M Luther
@ast
James M Luther
@es
James M Luther
@nl
James M Luther
@sl
James M. Luther
@en
type
label
James M Luther
@ast
James M Luther
@es
James M Luther
@nl
James M Luther
@sl
James M. Luther
@en
altLabel
MSCI James M. Luther, MD
@en
prefLabel
James M Luther
@ast
James M Luther
@es
James M Luther
@nl
James M Luther
@sl
James M. Luther
@en
P106
P21
P31
P3835
james-luther2
P496
0000-0001-7225-2897